| 05/26/2026 5:07 PM | Kosacz Barbara (1763316) Reporting XOMA (791908) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/26/2026 5:07 PM | Franklin Heather L (1436658) Reporting XOMA (791908) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/26/2026 5:08 PM | PERRY MATTHEW D (1454337) Reporting XOMA (791908) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/26/2026 5:08 PM | Hernday Natasha (1780547) Reporting XOMA (791908) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/26/2026 5:08 PM | LIMBER JOSEPH M (1216023) Reporting XOMA (791908) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/26/2026 5:08 PM | WYSZOMIERSKI JACK L (1023225) Reporting XOMA (791908) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/26/2026 10:28 AM | XOMA (791908) Subject | Form 425 | |
| 05/22/2026 5:01 AM | XOMA (791908) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 05/18/2026 4:26 PM | BIOTECHNOLOGY VALUE FUND L P (918923) Filed by XOMA (791908) Subject | Form SCHEDULE 13D/A | |
| 05/18/2026 4:29 PM | BIOTECHNOLOGY VALUE FUND II LP (1102444) Reporting BIOTECHNOLOGY VALUE FUND L P (918923) Reporting Biotechnology Value Trading Fund OS LP (1660683) Reporting BVF GP HOLDINGS LLC (1803809) Reporting BVF I GP LLC (1803805) Reporting BVF II GP LLC (1803806) Reporting BVF INC/IL (1056807) Reporting BVF PARTNERS L P/IL (1055947) Reporting BVF Partners OS Ltd. (1660684) Reporting LAMPERT MARK N (1233840) Reporting XOMA (791908) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/18/2026 8:11 AM | XOMA (791908) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
Get the Latest News and Ratings for XOMAO and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for XOMA and its competitors with MarketBeat's FREE daily newsletter.
|
| 05/18/2026 8:13 AM | XOMA (791908) Filer | Form DEFA14A | |
| 05/15/2026 8:03 AM | Woodline Partners LP (1784547) Filed by XOMA (791908) Subject | Form SCHEDULE 13G | |
| 05/12/2026 3:06 PM | XOMA (791908) Filer | Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
| 05/01/2026 8:15 PM | LIGAND PHARMACEUTICALS INC (886163) Filed by XOMA (791908) Subject | Form SCHEDULE 13D | |
| 04/30/2026 1:38 PM | VANGUARD CAPITAL MANAGEMENT LLC (2100119) Filed by XOMA (791908) Subject | Form SCHEDULE 13G | |
| 04/29/2026 4:43 PM | BIOTECHNOLOGY VALUE FUND L P (918923) Filed by XOMA (791908) Subject | Form SCHEDULE 13D/A | |
| 04/27/2026 6:37 PM | LIGAND PHARMACEUTICALS INC (886163) Filer XOMA (791908) Filer | Form DEFA14A | |
| 04/27/2026 3:12 PM | BlackRock, Inc. (2012383) Filed by XOMA (791908) Subject | Form SCHEDULE 13G | |
| 04/27/2026 3:01 PM | XOMA (791908) Filer | Form 8-K/A | |
| 04/27/2026 7:16 AM | XOMA (791908) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 04/27/2026 7:19 AM | XOMA (791908) Filer | Form DEFA14A | |
| 04/22/2026 3:30 PM | Sitko Bradley (1959809) Reporting XOMA (791908) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 04/22/2026 3:30 PM | Hughes Owen (1575933) Reporting XOMA (791908) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 04/22/2026 3:30 PM | Montano Maricel Perea (2076299) Reporting XOMA (791908) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 04/22/2026 3:30 PM | Trigilio Jeffrey (1838671) Reporting XOMA (791908) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 04/15/2026 5:13 PM | Trigilio Jeffrey (1838671) Reporting XOMA (791908) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/31/2026 3:30 PM | LIMBER JOSEPH M (1216023) Reporting XOMA (791908) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/30/2026 4:34 PM | XOMA (791908) Filer | Form DEFA14A | |
| 03/30/2026 4:35 PM | XOMA (791908) Filer | Form ARS | |
| 03/27/2026 1:14 PM | VANGUARD GROUP INC (102909) Filed by XOMA (791908) Subject | Form SCHEDULE 13G/A | |
| 03/26/2026 3:30 PM | WYSZOMIERSKI JACK L (1023225) Reporting XOMA (791908) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/18/2026 5:45 AM | XOMA (791908) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 03/17/2026 3:38 PM | Hughes Owen (1575933) Reporting XOMA (791908) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/13/2026 6:09 PM | Montano Maricel Perea (2076299) Reporting XOMA (791908) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/13/2026 6:09 PM | Trigilio Jeffrey (1838671) Reporting XOMA (791908) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/13/2026 6:09 PM | Sitko Bradley (1959809) Reporting XOMA (791908) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/06/2026 9:05 AM | FMR LLC (315066) Filed by XOMA (791908) Subject | Form SCHEDULE 13G/A | |
| 03/02/2026 5:04 AM | XOMA (791908) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 02/12/2026 1:36 PM | MORGAN STANLEY (895421) Filed by XOMA (791908) Subject | Form SCHEDULE 13G/A | |
| 02/09/2026 3:19 PM | XOMA (791908) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
Your $29.97 book is free today (Ad) Why Some Traders Skip Stocks Entirely
You don't need a big account to trade options.
In fact, options can give you up to 12 times the leverage of stocks — with a fraction of the capital tied up.
This free guide lays it all out in plain English — from A to Z, with step-by-step examples you can follow in your own account. Normally $29.97. Today it's free. Grab your copy now. |
| 01/30/2026 4:14 PM | Generation Bio Co. (1733294) Subject XOMA (791908) Filed by | Form SC TO-T/A | |
| 01/15/2026 3:25 PM | XOMA (791908) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 01/14/2026 3:30 PM | Trigilio Jeffrey (1838671) Reporting XOMA (791908) Issuer | Form 3 Initial statement of beneficial ownership of securities | |
| 01/14/2026 3:35 PM | Trigilio Jeffrey (1838671) Reporting XOMA (791908) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 01/12/2026 6:58 AM | Generation Bio Co. (1733294) Subject XOMA (791908) Filed by | Form SC TO-T/A | |
| 01/12/2026 6:00 AM | XOMA (791908) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 01/09/2026 3:05 PM | Generation Bio Co. (1733294) Subject XOMA (791908) Filed by | Form SC TO-T | |
| 12/15/2025 7:36 PM | Generation Bio Co. (1733294) Subject XOMA (791908) Filed by | Form SC TO-C | |
| 12/05/2025 8:15 AM | XOMA (791908) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 11/21/2025 6:50 AM | LAVA Therapeutics NV (1840748) Subject XOMA (791908) Filed by | Form SC TO-T/A | |
| 11/21/2025 7:03 AM | XOMA (791908) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 11/13/2025 6:16 AM | LAVA Therapeutics NV (1840748) Subject XOMA (791908) Filed by | Form SC TO-T/A | |
| 11/12/2025 6:46 AM | XOMA (791908) Filer | Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
| 11/12/2025 6:46 AM | XOMA (791908) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 10/17/2025 11:22 AM | LAVA Therapeutics NV (1840748) Subject XOMA (791908) Filed by | Form SC TO-T/A | |
| 10/03/2025 4:24 PM | XOMA (791908) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 10/03/2025 4:00 PM | XOMA (791908) Filer | Form 424B5 | |
| 10/03/2025 4:03 PM | XOMA (791908) Filer | Form 424B5 | |
| 10/02/2025 3:35 PM | LAVA Therapeutics NV (1840748) Subject XOMA (791908) Filed by | Form SC TO-T/A | |
| 09/26/2025 4:29 PM | XOMA (791908) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 09/23/2025 4:32 PM | Montano Maricel Perea (2076299) Reporting XOMA (791908) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 09/23/2025 4:32 PM | BURNS THOMAS M. (1638479) Reporting XOMA (791908) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 09/23/2025 4:32 PM | Hughes Owen (1575933) Reporting XOMA (791908) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 09/23/2025 4:32 PM | Sitko Bradley (1959809) Reporting XOMA (791908) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 09/23/2025 4:13 PM | XOMA (791908) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 09/17/2025 8:10 AM | HilleVax, Inc. (1888012) Subject XOMA (791908) Filed by | Form SC TO-T/A | |
| 09/12/2025 3:30 PM | Montano Maricel Perea (2076299) Reporting XOMA (791908) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 09/09/2025 3:07 PM | LAVA Therapeutics NV (1840748) Subject XOMA (791908) Filed by | Form SC TO-T/A | |
| 09/03/2025 4:15 PM | LAVA Therapeutics NV (1840748) Subject XOMA (791908) Filed by | Form SC TO-T/A | |
| 08/18/2025 7:23 AM | HilleVax, Inc. (1888012) Subject XOMA (791908) Filed by | Form SC TO-T | |
| 08/15/2025 7:49 AM | LAVA Therapeutics NV (1840748) Subject XOMA (791908) Filed by | Form SC TO-T | |
| 08/14/2025 3:10 PM | Montano Maricel Perea (2076299) Reporting XOMA (791908) Issuer | Form 3 Initial statement of beneficial ownership of securities | |
| 08/14/2025 3:11 PM | Montano Maricel Perea (2076299) Reporting XOMA (791908) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 08/13/2025 6:45 AM | XOMA (791908) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 08/13/2025 6:41 AM | XOMA (791908) Filer | Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
| 08/11/2025 8:15 AM | Turnstone Biologics Corp. (1764974) Subject XOMA (791908) Filed by | Form SC TO-T/A | |
| 08/06/2025 11:19 AM | FMR LLC (315066) Filed by XOMA (791908) Subject | Form SCHEDULE 13G/A | |
| 08/04/2025 7:05 AM | LAVA Therapeutics NV (1840748) Subject XOMA (791908) Filed by | Form SC TO-C | |
| 08/04/2025 6:32 AM | HilleVax, Inc. (1888012) Subject XOMA (791908) Filed by | Form SC TO-C | |
| 07/29/2025 1:54 PM | VANGUARD GROUP INC (102909) Filed by XOMA (791908) Subject | Form SCHEDULE 13G | |
| 07/11/2025 5:05 AM | Turnstone Biologics Corp. (1764974) Subject XOMA (791908) Filed by | Form SC TO-T | |
| 07/02/2025 3:30 PM | Sitko Bradley (1959809) Reporting XOMA (791908) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/27/2025 7:00 AM | Turnstone Biologics Corp. (1764974) Subject XOMA (791908) Filed by | Form SC TO-C | |